Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Current Assets: 2022-2025

Historic Current Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $12.9 million.

  • InMed Pharmaceuticals' Current Assets rose 48.35% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 48.35%. This contributed to the annual value of $12.9 million for FY2025, which is 48.08% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Current Assets of $12.9 million as of FY2025, which was up 48.08% from $8.7 million recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Current Assets registered a high of $12.9 million during FY2025, and its lowest value of $8.7 million during FY2024.
  • Its 3-year average for Current Assets is $11.0 million, with a median of $11.3 million in 2023.
  • Per our database at Business Quant, InMed Pharmaceuticals' Current Assets declined by 23.32% in 2024 and then surged by 48.08% in 2025.
  • Over the past 4 years, InMed Pharmaceuticals' Current Assets (Yearly) stood at $9.6 million in 2022, then grew by 18.07% to $11.3 million in 2023, then declined by 23.32% to $8.7 million in 2024, then spiked by 48.08% to $12.9 million in 2025.